Dr. Reinhard Gabathuler, biOasis Technologies Inc., Vancouver, Canada
| Start Date | 14.03.2012 - 17:00 |
| Event End | 14.03.2012 - 17:00 |
| Location | Universität Basel, Pharmazentrum |
elopment of a new peptide vector Transcend (melanotransferrin) for brain delivery of therapies for the treatment of brain diseases